Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 50.41% | 53.61% | 52.77% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.41% | 53.61% | 52.77% | -- | -- |
| Cost of Revenue | -32.13% | -28.82% | -29.24% | -- | -- |
| Gross Profit | 159.37% | 160.19% | 158.73% | -- | -- |
| SG&A Expenses | 51.74% | 46.02% | 14.58% | -- | -- |
| Depreciation & Amortization | -0.80% | 38.28% | 87.23% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.40% | -6.76% | -9.99% | -- | -- |
| Operating Income | 14.76% | 15.37% | 18.51% | -- | -- |
| Income Before Tax | -3.68% | -3.47% | -2.64% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.68% | -3.47% | -2.64% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.68% | -3.47% | -2.64% | -- | -- |
| EBIT | 14.76% | 15.37% | 18.51% | -- | -- |
| EBITDA | 14.71% | 15.08% | 18.24% | -- | -- |
| EPS Basic | -2.88% | -1.89% | -0.91% | -- | -- |
| Normalized Basic EPS | -3.08% | -1.52% | -1.47% | -- | -- |
| EPS Diluted | -57.35% | -54.29% | -50.00% | -- | -- |
| Normalized Diluted EPS | -3.08% | -1.52% | -1.47% | -- | -- |
| Average Basic Shares Outstanding | 0.44% | 0.48% | 0.49% | -- | -- |
| Average Diluted Shares Outstanding | 0.50% | 0.62% | 0.66% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
